~wired | Bookmarks (17)

Researchers think a combination of genetic edits and an experimental immunosuppressive drug could make the first pig kidney transplant a long-term success.

Donor livers are in short supply for transplants. A startup is attempting to grow new ones in people instead.

A 62-year-old Massachusetts man with failing kidneys is the first living patient to receive a genetically altered kidney from a pig.

In a livestream on X, the paralyzed 29-year-old man used his Neuralink brain implant to control a computer.

Your pets can already eat a chewable tablet for tick prevention. Now, a pill that paralyzes and kills ticks has shown positive results in a small human trial.

De-extinction startup Colossal Biosciences claims it has found a way to reprogram elephant cells, a technical breakthrough that could lead to the return of the long-lost mammals.

Americans eat too much sugar. Food tech company Zya is developing a substance to add to sweet foods that can convert some of that sugar into fiber in the digestive system.

Elon Musk says Neuralink’s first human trial subject can control a computer mouse with their brain, but some researchers are frustrated by a lack of information about the study.

Houston-based rBIO has invented a new process to churn out insulin at higher yields using custom-made bacteria.

Several gene therapies aim to restore a protein necessary for transmitting sound signals from the ear to the brain.

Strand Therapeutics has figured out a way to turn the molecule on and off in certain tissues to more precisely treat tumors.

Biotech company Contraline has safely implanted a sperm-blocking hydrogel in 23 men. It’s designed to be a fully reversible vasectomy.

Thanks in part to Elon Musk, the field of brain-computer interfaces has captured both public and investor interest, with a cadre of companies now developing implantable devices.

The approval of the first Crispr-based therapy is just the beginning. Getting it to patients is the next hurdle.